Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma

References

• Ng JH, Iyer NG, Tan M-H, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39:297–304. doi:10.1002/hed.2458927696557
   PubMed Web of Science ®Google Scholar
• Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29:1488–1494. doi:10.1200/JCO.2010.31.788321383286
   PubMed Web of Science ®Google Scholar
• Chen MF, Tsai MS, Chen WC, Chen PT. Predictive value of the pretreatment neutrophil-to-lymphocyte ratio in head and neck squamous cell carcinoma. J Clin Med. 2018;20:7.
   Google Scholar
• Mascarella MA, Mannard E, Silva SD, Zeitouni A. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis. Head Neck. 2018;40:1091–1100. doi:10.1002/hed.2507529356179
   PubMed Web of Science ®Google Scholar
• Rosculet N, Zhou XC, Ha P, et al. Neutrophil-to-lymphocyte ratio: prognostic indicator for head and neck squamous cell carcinoma. Head Neck. 2017;39:662–667. doi:10.1002/hed.2465828075517
   PubMed Web of Science ®Google Scholar
• Sumner WA, Stokes WA, Oweida A, et al. Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy. J Transl Med. 2017;15:168. doi:10.1186/s12967-017-1268-728764811
   PubMed Web of Science ®Google Scholar
• Valero C, Pardo L, López M, et al. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer. Head Neck. 2017;39:219–226. doi:10.1002/hed.2456127534525
   PubMed Web of Science ®Google Scholar
• Fang Q, Liu F, Seng D. Oncologic outcome of parotid mucoepidermoid carcinoma in pediatric patients. Cancer Manag Res. 2019;11:1081–1085. doi:10.2147/CMAR.S19278830774436
   PubMed Web of Science ®Google Scholar
• Fang Q, Li P, Qi J, Luo R, Chen D, Zhang X. Value of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue. Laryngoscope. 2019. doi:10.1002/lary.27927
   Google Scholar
• Blanchard P, Belkhir F, Temam S, et al. Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis. Eur Arch Otorhinolaryngol. 2017;274:1683–1690. doi:10.1007/s00405-016-4419-127933385
   PubMed Web of Science ®Google Scholar
• Fang QG, Shi S, Liu FY, Sun CF. Squamous cell carcinoma of the oral cavity in ever smokers: a matched-pair analysis of survival. J Craniofac Surg. 2014;25:934–937. doi:10.1097/SCS.000000000000071024820715
   PubMed Web of Science ®Google Scholar
• Bachar G, Hod R, Goldstein DP, et al. Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. Oral Oncol. 2011;47:45–50. doi:10.1016/j.oraloncology.2010.11.00321167767
   PubMed Web of Science ®Google Scholar
• Farquhar DR, Tanner AM, Masood MM, et al. Oral tongue carcinoma among young patients: an analysis of risk factors and survival. Oral Oncol. 2018;84:7–11. doi:10.1016/j.oraloncology.2018.06.01430115478
   PubMed Web of Science ®Google Scholar
• Hilly O, Shkedy Y, Hod R, et al. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49:987–990. doi:10.1016/j.oraloncology.2013.07.00523927849
   PubMed Web of Science ®Google Scholar
• Pitman KT, Johnson JT, Wagner RL, Myers EN. Cancer of the tongue in patients less than forty. Head Neck. 2000;22:297–302.10748455
   PubMed Web of Science ®Google Scholar
• Friedlander PL, Schantz SP, Shaha AR, Yu G, Shah JP. Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck. 1998;20:363–368.9663661
   PubMed Web of Science ®Google Scholar
• Gerson SJ. Oral cancer. Crit Rev Oral Biol Med. 1990;1:153–166. doi:10.1177/104544119000100301012129624
   PubMedGoogle Scholar
• Chen AM, Chen LM, Vaughan A, et al. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. Am J Clin Oncol. 2011;34:270–275. doi:10.1097/COC.0b013e3181dea40b20622648
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang H, Xue Y, et al. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas. Cancer Med. 2017;6:910–917. doi:10.1002/cam4.104528378539
   PubMed Web of Science ®Google Scholar
• Abbate V, Dell’Aversana Orabona G, Salzano G, et al. Pre-treatment Neutrophil-to-Lymphocyte Ratio as a predictor for occult cervical metastasis in early stage (T1-T2 cN0) squamous cell carcinoma of the oral tongue. Surg Oncol. 2018;27:503–507. doi:10.1016/j.suronc.2018.06.00230217309
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang H, Yan A, et al. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis. BMC Cancer. 2018;18:383. doi:10.1186/s12885-018-4242-829618336
   PubMed Web of Science ®Google Scholar
• Kano S, Homma A, Hatakeyama H, et al. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck. 2017;39:247–253. doi:10.1002/hed.2457627617428
   PubMed Web of Science ®Google Scholar
• Tecchio C, Scapini P, Pizzolo G, Cassatella MA. On the cytokines produced by human neutrophils in tumors. Semin Cancer Biol. 2013;23:159–170. doi:10.1016/j.semcancer.2013.02.00423410636
   PubMed Web of Science ®Google Scholar
• Kawakita D, Tada Y, Imanishi Y, et al. Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan. Oncotarget. 2017;8:1083–1091. doi:10.18632/oncotarget.1356527894101
   PubMedGoogle Scholar
• Liu F, Cheng G, Fang Q, Sun Q. Natural history of untreated squamous cell carcinoma of the head and neck. Clin Otolaryngol. 2018; Epub ahead of print. doi:10.1111/coa.13260.
   Web of Science ®Google Scholar
• Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107:864–873. doi:10.1038/bjc.2012.34722878371
   PubMed Web of Science ®Google Scholar